George Deraos

Patras Science Park
Patra, ESYE23 26500, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Development of Methamphetamine Conjugated Vaccine through Hapten Design: In Vitro and In Vivo Characterization.

Development of Methamphetamine Conjugated Vaccine through Hapten Design: In Vitro and In Vivo Characterization.

Journal: Vaccines

Published: January 04, 2023

Development and characterization of a novel conjugated methamphetamine vaccine.

Development and characterization of a novel conjugated methamphetamine vaccine.

Journal: Vaccine

Published: January 23, 2022

Myelin Peptide-Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient.

Myelin Peptide-Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine Ingredient.

Journal: Vaccines

Published: October 04, 2021

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82⁻98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II.

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82⁻98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II.

Journal: Brain sciences

Published: November 20, 2018

Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis.

Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis.

Journal: Bioorganic & medicinal chemistry

Published: October 30, 2017

Cyclic MOG35-55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis.

Cyclic MOG35-55 ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis.

Journal: Bioorganic & medicinal chemistry

Published: May 11, 2017

Cyclic citrullinated MBP87-99 peptide stimulates T cell responses: Implications in triggering disease.

Cyclic citrullinated MBP87-99 peptide stimulates T cell responses: Implications in triggering disease.

Journal: Bioorganic & medicinal chemistry

Published: October 03, 2016

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.

Journal: International journal of molecular sciences

Published: July 13, 2016

Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.

Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.

Journal: European journal of medicinal chemistry

Published: September 29, 2014

Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease.

Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 03, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026